Join Ian Chucher, SVP Drug Discovery at BenevolentAI for a talk on Artificial Intelligence - From Data to Drugs at the Royal Society of Medicine. Ian will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases.
Join Alix Lacoste VP Data Science and Michelle Gill, Senior Data Scientist at BenevolentAI for a presentation on "Machine Learning for Target Identification and Lead Optimization in Drug Discovery".
Join Joanna Shields, CEO at BenevolentAI for a speech at the Digital-Life-Design conference in Munich. DLD stands for Digital, Life, Design and explores how the digital age fundamentally changes our lives, society and business.
Join Joanna Shields, CEO at BenevolentAI for a keynote at the JP Morgan Healthcare Conference. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community
Join Joanna Shields, CEO BenevolentAI, Robert Nelsen, Co-Founder & Managing Director, ARCH Venture Partners and Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation at The Forbes Healthcare Summit for a panel on How Smart Is Artificial Intelligence
Join Mark Davies at Global Engage congress on pharmaceuticals research & development. Mark Davies will present on how Artificial Intelligence (AI) is disrupting drug discovery.
Join Jackie Hunter at the Endpoints London Biotech Summit for a discussion on ROI and Innovation in drug development: What are the big and little biopharmas doing to change the equation?
Join Marwin Segler, Lead Machine Learning Researcher at Elrig event on Drug Discovery for Small & Large Molecules
This September, Marc Davies, VP Biomedical Informatics will be presenting at the Artificial Intelligence in Drug Development Congress on how machine learning technologies are changing how new medicines are discovered and developed.
Join Mark Rackham, Drug discovery scientist at BenevolentAI for a panel discussion on Precision Medicine and Biomarker Discovery
Join Nasrin Mostafazadeh at the NLP Seminar Series organised at Stanford University on the 30 November